What is Upper Hand Genetics?
Upper Hand Genetics is at the forefront of agricultural innovation, specializing in advanced genetic testing and analysis services. Their cutting-edge solutions are engineered to bolster crop yield and enhance resilience through sophisticated genetic insights. The company's primary clientele includes farmers, agricultural researchers, and agribusinesses keen on optimizing their crop management strategies. By prioritizing sustainability and operational efficiency, Upper Hand Genetics is dedicated to empowering the agricultural industry to navigate the complexities of modern farming.
How much funding has Upper Hand Genetics raised?
Upper Hand Genetics has raised a total of $22K across 1 funding round:
Debt
$22K
Debt (2021): $22K with participation from PPP
Key Investors in Upper Hand Genetics
PPP
Public-Private Partnership
What's next for Upper Hand Genetics?
With the recent influx of expansion capital, Upper Hand Genetics is poised for significant growth and market penetration. The substantial funding at this Series B/C stage suggests a strategic focus on scaling operations, potentially expanding research and development initiatives, and broadening their service offerings to a wider agricultural base. This investment will likely fuel advancements in their genetic solutions, enabling them to further support the agricultural sector in achieving greater productivity and sustainability.
See full Upper Hand Genetics company page
